DNA variation and brain region-specific expression profiles exhibit different relationships between inbred mouse strains: implications for eQTL mapping studies
-
* Corresponding author: Carrolee Barlow cbarlow@braincellsinc.com
- Equal contributors
Genome Biology 2007, 8:R25 doi:10.1186/gb-2007-8-2-r25
Accesses
- Last 30 days: 39 accesses
- Last year: 743 accesses
- All time: 5488 accesses
Cited by
BioMed Central: 5 citations
|
Harry A Noyes, Morris Agaba, Susan Anderson, Alan L Archibald, Andy Brass, John Gibson, Laurence Hall, Helen Hulme, Sung Oh, Stephen Kemp BMC Genomics 2010, 11:361 (7 June 2010) |
|
Simone de Jong, Tova F Fuller, Esther Janson, Eric Strengman, Steve Horvath, Martien JH Kas, Roel A Ophoff BMC Genomics 2010, 11:20 (11 January 2010) |
|
Promoter architecture and the evolvability of gene expression Itay Tirosh, Naama Barkai, Kevin J Verstrepen Journal of Biology 2009, 8:95 (14 December 2009) Major evolutionary change depends on changes in gene expression. Itay Tirosh and colleagues review recent research on the influence of promoter architecture and mutations in regulatory proteins on divergent expression patterns and suggest what is required for evolvability.
|
|
Anna-Karin Persson, Mathias Gebauer, Suzana Jordan, Christiane Metz-Weidmann, Anke M Schulte, Hans-Christoph Schneider, Danping Ding-Pfennigdorff, Jonas Thun, Xiao-Jun Xu, Zsuzsanna Wiesenfeld-Hallin, Ariel Darvasi, Kaj Fried, Marshall Devor Molecular Pain 2009, 5:7 (19 February 2009) |
|
Morphine effects on striatal transcriptome in mice Michal Korostynski, Marcin Piechota, Dorota Kaminska, Wojciech Solecki, Ryszard Przewlocki Genome Biology 2007, 8:R128 (28 June 2007) Global transcriptional analysis of mouse striata following acute and chronic exposure to morphine reveals multiple physiological factors which may affect opioid-related phenotypes and implicates a number of gene networks, including glucocorticoid receptor regulated genes, in the response to this opioid. |